Totality (n, %) | No recurrence (n, %) | Recurrence (n, %) | P value | Recurrence interval (m, mean) | P value | Infertility (n, %) | Pregnancy (n, %) | P value | |
---|---|---|---|---|---|---|---|---|---|
Total number | 122 | 114 (93.4 %) | 8 (6.6 %) | N/A | 25.9 | 11 (24.4 %) | 34 (75.6 %) | ||
Age (y, mean ± SD) | 30.2 ± 7.3 | 30.3 ± 7.3 | 29.1 ± 6.8 | 0.65 | N/A | 29.7 ± 4.4 | 27.6 ± 4.5 | 0.19 | |
Parity | |||||||||
Multiparous | 43 (35.2 %) | N/A | N/A | N/A | |||||
Nulliparous | 79 (64.8 %) | ||||||||
Tumor marker CA125 (tested) | 83 | ||||||||
Normal | 54 (65.1 %) | 50 (92.6 %) | 4 (7.4 %) | 0.69 | 25.7 | 0.00 | N/A | ||
Elevated | 29 (34.9 %) | 26 (89.7 %) | 3 (10.3 %) | 22.4 | |||||
Lesion location | |||||||||
Inner-ovary | 94 (77.0 %) | 89 (94.7 %) | 5 (5.3 %) | 0.38 | 31.9 | 0.00 | 6 (18.8 %) | 26 (81.2 %) | 0.25 |
Extra-ovary | 28 (23.0 %) | 25 (89.3 %) | 3 (10.7 %) | 22.1 | 5 (38.5 %) | 8 (61.5 %) | |||
Lesion size (cm ± SD) | 10.5 ± 7.0 | 10.4 ± 7.0 | 12.0 ± 7.9 | 0.59 | N/A | 8.7 ± 4.7 | 10.1 ± 6.8 | 0.52 | |
Lesion lateral | |||||||||
Unilateral | 106 (86.9 %) | 101 (95.3 %) | 5 (4.7 %) | 0.07 | 33.2 | 0.00 | 8 (22.9 %) | 27 (77.1 %) | 0.69 |
Bilateral | 16 (13.1 %) | 13 (81.3 %) | 3 (18.7 %) | 23.0 | 3 (30.0 %) | 7 (70.0 %) | |||
FIGO stage | |||||||||
Stage I | 111 (91.0 %) | 104 (93.7 %) | 7 (6.3 %) | 0.54 | 30.4 | N/A | 8 (20.0 %) | 32 (80.0 %) | 0.09 |
> = Stage II | 11 (9.0 %) | 10 (90.9 %) | 1 (9.1 %) | 26.0 | 3 (60.0 %) | 2 (40.0 %) | |||
Pathology types | |||||||||
Endometriod | 5 (4.1 %) | 4 (80.0 %) | 1 (20.0 %) | 0.29 | 21.0 | N/A | 0 | 3 (100 %) | 0.57 |
Serous and/or mucious | 117 (95.9 %) | 110 (94.0 %) | 7 (6.0 %) | 30.8 | 11 (26.2 %) | 31 (73.8 %) | |||
Serous | 64 (52.5 %) | 60 (93.8 %) | 4 (6.2 %) | 1.00 | 35.9 | 0.00 | 9 (32.1 %) | 19 (67.9 %) | 0.45 |
Mucinous | 51 (41.8 %) | 48 (94.1 %) | 3 (5.9 %) | 18.5 | 2 (15.4 %) | 11 (84.6 %) | |||
Serous and mucinous | 2 (1.6 %) | 2 | 0 | N/A | 0 | 1 | N/A |